Endoscopic Visceral Lipectomy Video
Medical animated video illustrating the new minimally invasive method and device BioSculpture Technology is developing as a potentially safer and cheaper treatment of obesity, metabolic syndrome and type 2 diabetes mellitus.
Although the company believes Endoscopic Visceral Lipectomy will do for obesity surgery what LASIK did for vision correction, ("EVL") has not yet been proven safe and effective nor received regulatory approval.
BioSculpture Technology, Inc.
April 26, 2017 -- BioSculpture Technology, Inc. has a Direct Public Offering of a Qualified Tier 2 Regulation A Registration to fund development of a new minimally invasive treatment of Obesity and Type 2 Diabetes. The Company's CEO, Robert L. Cucin, MD discusses the problem and the Company's proposed solution.